SUBSCRIBE
SUBSCRIBE
News   Business

Avigen, Inc. Fires CEO, Stays Neutral on Offer

March 27, 2009 | 
1 min read

San Francisco Business Times -- Drug developer Avigen Inc., while firing its CEO and two others officers, said it has stopped merger discussions and will liquidate if board nominees from its largest shareholders are not elected Friday.

People
MORE ON THIS TOPIC
Hands in black and white dropping a collection of pills on a pink background
Manufacturing
Viking Secures 1B Supply of Obesity Pill Candidate With $150M Prepayment Deal
March 11, 2025
 · 
2 min read
 · 
Annalee Armstrong
Dollar banknote cut into pieces on a yellow background
Gene therapy
Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit
March 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Trendy halftone collage. Concept of contracting, negotiation, contracting, favorable terms. Trendy modern retro illustration on business theme. Concept of teamwork. Vector illustration
Mergers & acquisitions
BMS Buys Abecma Partner 2seventy for $286M, Ending Cost Sharing Agreement
March 11, 2025
 · 
3 min read
 · 
Tristan Manalac
Composite photo collage of hand hold magnifier glass research examine secret object question mark secret isolated on painted background.
Editorial
This Might Be a Moot Point but the FDA’s Priority Review Vouchers Need Transparency
March 7, 2025
 · 
3 min read
 · 
Annalee Armstrong